Johnson & Johnson sees $110M talc verdict overturned – Wanting for Alpha
Business

Johnson & Johnson sees $110M talc verdict overturned – Wanting for Alpha

An appeals court in Missouri has overturned a $110M verdict in opposition to Johnson & Johnson (NYSE:JNJ) over whether or not its talc introduced about ovarian cancer.

That reverses a 2017 decision in prefer of a Virginia woman who says she developed the cancer after decades of the narrate of the talc for feminine hygiene.

The appeals court cited a inform supreme court ruling limiting out-of-inform plaintiffs’ capability to sue within the inform.

The firm peaceable faces several assorted proceedings in St. Louis, including the one who introduced a checklist $Four.69B talc verdict in opposition to it.

Read More

October 16, 2019
Twitter
Flickr
ABOUT

Paper Post brings the top and important news from the top news media of the world. You can send us any local news & we will verify and publish it. We believe that our earth is for everyone & if you want to make it better  for everyone then write & help us.

support@paperpost.org